Search Results
51 items found for "Pamela S Becker"
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s
- New role of β-arrestins in MOR signaling
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5391-3. doi: 10.1073/pnas.90.12.5391. Faouzi A, Varga BR, Majumdar S. Biased Opioid Ligands. Shiraki A, Shimizu S.
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Defensins and Mrgpra2 were critical for combating S. aureus infections and the formation of neutrophil
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
December 2021 OMass Therapeutics 's founder, Carol Robinson , has been awarded the prestigious Louis-Jeantet
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. And Advance Novel Oral Small Molecule Medicines Targeting G Protein-Coupled Receptors Novo Nordisk A/S:
- VAMP2: a crucial player in the delivery of MOR to the synapse
Jurado, S., D. Goswami, Y. Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Schoch, S., F. Deak, A. K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T.
- Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
domain (WAP) is necessary for this modulatory activity, although data from GST pull-down (glutathione-S-transferase
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
These data will be shared as an oral presentation by Ron S.
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
through cAMP/protein kinase A signaling, consistent with AVPR2 coupling to the G protein subunit alpha s.
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
The results provide rationale for considering a combination(s) of FDA-approved SFK (dasatinib) and MEK
- Adhesion GPCR Consortium Newsletter - May 2024
I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked No wonder why Mexican cuisine has obtained the coveted status of UNESCO ́s Intangible Cultural Heritage
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
Further research is required to fully delineate their role(s)."
- 📰 GPCR Weekly News - January 2 to 8, 2023
s Director Stephen A.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Proc Natl Acad Sci U S A, 2020. 117(35): p. 21723-21730. 2.
- 📰 GPCR Weekly News, February 13 to 19, 2023
In Anesthesiology Neurocrine Biosciences discovers new muscarinic M4 receptor antagonists Alexander S.
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
s Check out the details of each course below: Open to the Public: Enrollment is Now Available!
- 📰 GPCR Weekly News, November 6 to November 12, 2023
and cross-reactivity in tachykinin NK1 and NK2 receptors GPCR Binders, Drugs, and more Discovery of (S)
- 📰 GPCR Weekly News, May 8 to 14, 2023
Committee Recommends Continuing Study Addex Therapeutics in the 23rd BioEquity Europe Conference Simon Bekker-Jensen
- 📰 GPCR Weekly News, November 13 to 19, 2023
receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor NTR-1's
- Regulators of G-protein signaling: essential players in GPCR signaling
Hollinger, S. and J.R.
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Disease s
- Ode to GPCRs
S. of. S. Non-traditional roles of G protein-coupled receptors in basic cell biology.